How Chemoproteomics Can Enable Drug Discovery and Development
- 1 January 2012
- journal article
- review article
- Published by Elsevier in Chemistry & Biology
- Vol. 19 (1) , 11-22
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinaseBioorganic & Medicinal Chemistry Letters, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase InhibitorsChemistry & Biology, 2011
- In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native KinasesChemistry & Biology, 2011
- A Potent and Selective Inhibitor of KIAA1363/AADACL1 that Impairs Prostate Cancer PathogenesisChemistry & Biology, 2011
- Photoreactive Stapled BH3 Peptides to Dissect the BCL-2 Family InteractomeChemistry & Biology, 2010
- Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia ProteinCancer Cell, 2010
- Contemporary strategies for the stabilization of peptides in the α-helical conformationCurrent Opinion in Chemical Biology, 2008
- Chemical Proteomic Probes for Profiling Cytochrome P450 Activities and Drug Interactions In VivoChemistry & Biology, 2007
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006